EUVIMEDEUVIMED entdecken
Crossref

Perioperative daptomycin for prophylaxis of vancomycin‐resistant Enterococcus infection in colonized liver transplant recipients

Jordan T Mak iD, Seung Ha iD, Sarah Perloff iD, John P Knorr iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Jordan T Mak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jefferson Einstein Hospital, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Daptomycin, Liver Transplantation, Gram-Positive Bacterial Infections, Vancomycin-Resistant Enterococci. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infection with vancomycin‐resistant Enterococcus (VRE) in liver transplant recipients (LTR) has been associated with extended hospital stays, increased readmission rates, graft failure, and death. A tailored perioperative surgical prophylaxis regimen targeting VRE may reduce postoperative infections in VRE‐colonized patients. This study investigated the outcomes of perioperative daptomycin in this patient population.

Methods

This retrospective, single‐center cohort study included LTR ≥ 18 years old who were VRE‐colonized from June 2018 to November 2022. VRE colonization was identified by a VRE rectal swab screen or a positive VRE culture prior to transplant. Two groups were analyzed: daptomycin versus no daptomycin. All LTR received perioperative piperacillin‐tazobactam for 24 h. If VRE‐colonized, one dose of daptomycin (6 mg/kg) was given pre‐ and postoperatively. Demographics, clinical characteristics, risk factors for VRE infection, and daptomycin dose were collected. The primary outcome was VRE infection at 14 days and 90 days post‐transplant.

Results

There were 36 VRE‐colonized LTR; 19 received daptomycin and 17 did not. Baseline characteristics and risk factors for VRE infection were similar between groups. More VRE infections occurred in the no daptomycin group within 14 days post‐transplant (24% vs. 0%, p = .04), but at 90 days posttransplant there was no significant difference (29% vs. 16%, p = .43). The average daptomycin dose was 7.1 mg/kg.

Conclusion

Perioperative daptomycin reduced the rate of VRE infections in VRE‐colonized LTR within 14 days posttransplant but not at 90 days. Future studies should evaluate if higher doses and/or longer duration of perioperative daptomycin can reduce VRE infections beyond 14 days post‐transplant. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DaptomycinLiver TransplantationGram-Positive Bacterial InfectionsVancomycin-Resistant EnterococciHumansAdolescentVancomycinAnti-Bacterial AgentsRetrospective StudiesCohort StudiesVancomycin ResistanceRisk Factors

Stichwörter der Autor:innen

daptomycinliver transplantperioperative prophylaxisvancomycin-resistant Enterococcus

Substanzen

DaptomycinVancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Jefferson Einstein Hospital, Philadelphia, Pennsylvania, USA.
  • Department of Internal Medicine, Division of Infectious Diseases, Jefferson Einstein Hospital, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Jordan T Mak, Seung Ha, Sarah Perloff, John P Knorr

Zitieren

APA

Mak, J. T., Ha, S., Perloff, S., & Knorr, J. P. (2024). Perioperative daptomycin for prophylaxis of vancomycin‐resistant Enterococcus infection in colonized liver transplant recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14186

Vancouver

Mak JT, Ha S, Perloff S, Knorr JP. Perioperative daptomycin for prophylaxis of vancomycin‐resistant Enterococcus infection in colonized liver transplant recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14186

BibTeX
@article{Mak2024,
  author = {Mak, Jordan T and Ha, Seung and Perloff, Sarah and Knorr, John P},
  title = {Perioperative daptomycin for prophylaxis of vancomycin‐resistant Enterococcus infection in colonized liver transplant recipients},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14186}
}
Kostenlos starten →